
Medplus Health Services Ltd. (MEDPLUS) 52 Week Low Streak: Why MEDPLUS Keeps Hitting New Lows
Updated: 9 Oct 2026 • 9:30 am
Posted by:

Medplus Health Services Ltd. has now set a fresh 52-week low for its second straight session, with MEDPLUS slipping 2.86% across the streak to Rs 626.45 at the latest trough. The current price stood at Rs 628.3, and Univest data confirms the repeated-low pattern but does not establish a company-specific cause for the continued decline.
With market capitalisation at Rs 7,770.47 crore, this Medplus Health Services Ltd. 52 Week Low Streak is more than a one-day breakdown. For a reader, the repeated print of a new yearly low matters because it shows that the weakness has persisted beyond the first break, even though the latest Univest data does not explain why the stock has kept making fresh lows.
Medplus Health Services Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 628.3 |
| Previous Close | Rs 631.7 |
| Today's Move | Rs -3.4 (-0.54%) |
| Open | Rs 635.75 |
| High | Rs 635.75 |
| Low | Rs 626.45 |
| Market Capitalisation | Rs 7,770.47 crore |
Medplus Health Services Ltd. (MEDPLUS) traded at Rs 628.3 versus the previous close of Rs 631.7, a fall of 0.54%. The stock opened at Rs 635.75, reached a high of Rs 635.75, touched a low of Rs 626.45.
At 09 October 2026 at 9:22 AM IST, MEDPLUS was trading at Rs 628.3, down Rs 3.4 or 0.54% from the previous close of Rs 631.7. The day opened at Rs 635.75, matched the high at Rs 635.75 and touched a low of Rs 626.45, which also marked the fresh 52-week low. The latest traded price sat near the lower end of the day’s range, reinforcing the weakness visible in the Medplus Health Services Ltd. 52 Week Low Streak.
The stock’s market capitalisation of Rs 7,770.47 crore places this move in a large, followed consumer healthcare and pharmacy retail business, but size alone does not explain the decline. The important point for the Medplus Health Services Ltd. 52 Week Low Streak is that the session remained below the prior close and extended the repeated yearly-low pattern from the previous trading day. Because this is a decline story, the focus stays on the breakdown and not on any recovery narrative.
What the Repeated 52-Week Lows Show
The Medplus Health Services Ltd. 52 Week Low Streak now spans two straight sessions, and the cumulative decline across that run is 2.86%. That matters because the pattern is not just a single-day dip: the stock has been resetting its 52-week low on each of the last two trading sessions. The medplus health services ltd. 52 week low streak therefore signals a persistent downward phase rather than an isolated intraday slip.
The latest low of Rs 626.45 is only marginally below the current traded price of Rs 628.3, which shows that the stock remained close to the trough at the time of the article timestamp.For readers tracking the Medplus Health Services Ltd. 52 Week Low Streak, the key takeaway is simple: the latest Univest figures confirm the repeated break lower, while the data does not identify a single operational or market catalyst.
Medplus Health Services Ltd. (MEDPLUS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,770.47 crore |
| P/E Ratio | 36.06x |
| P/B Ratio | 3.79x |
| ROE | 11.93% |
| ROCE | 22.22% |
| EPS | Rs 17.52 |
| Book Value Per Share | Rs 166.52 |
| Dividend Yield | 0% |
Medplus Health Services Ltd. (MEDPLUS) fundamental metrics show P/E 36.06x, P/B 3.79x, ROE 11.93%, ROCE 22.22%. These ratios show where the company stands today and are not a call to buy or sell.
Medplus Health Services Ltd. has a market capitalisation of Rs 7,770.47 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.06x, P/B at 3.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.93% and ROCE of 22.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.52, book value per share of Rs 166.52, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 24.03x, median ROE of 12.64%, median ROCE of 18.37%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Retailing |
| Industry | Retailing |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.06x |
| Benchmark Median P/E | 24.03x |
| Benchmark Average P/E | 64.22x |
| Benchmark P/E Range | 0.92x to 1,432.07x |
| Company P/B Ratio | 3.79x |
| Benchmark Median P/B | 2.38x |
| Company ROE | 11.93% |
| Benchmark Median ROE | 12.64% |
| Company ROCE | 22.22% |
| Benchmark Median ROCE | 18.37% |
| Company Market Capitalisation | Rs 7,770.47 crore |
| Benchmark Median Market Cap | Rs 178.53 crore |
Medplus Health Services Ltd. (MEDPLUS) operates in the Retailing sector, within the Retailing industry.
Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 36.06x, which is above the benchmark median of 24.03x, a difference of +50.06%. A P/E difference of this kind is a reference point rather than a recommendation.
Medplus Health Services Ltd. (MEDPLUS) has a ROE of 11.93%, which is below the benchmark median of 12.64%, a difference of -5.62%. Medplus Health Services Ltd. (MEDPLUS) has a ROCE of 22.22%, which is above the benchmark median of 18.37%, a difference of +20.96%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aditya Vision Ltd. | AVL | 7,795.42 | 56.09 | 10.18 | 18.55 | 20.82 |
| Electronics Mart India Ltd. | EMIL | 8,133.59 | 36.05 | 4.25 | 6.81 | 11.84 |
| Ethos Ltd. | ETHOSLTD | 7,037.14 | 66.8 | 4.57 | 7.78 | 13.7 |
| PN Gadgil Jewellers Ltd. | PNGJL | 8,782.11 | 19.35 | 3.12 | 23.31 | 21.8 |
| ADITYA BIRLA LIFES BRAN L | ABLBL | 8,970.83 | 49.92 | 6.27 | 24.67 | 27.34 |
Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 36.06x compared with the displayed peer median of 49.92x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.93% compares with a peer median of 18.55% across the companies shown in the table. ROCE stood at 22.22% versus the displayed peer median of 20.82%, providing a capital-efficiency comparison. Medplus Health Services Ltd. (MEDPLUS) has a market capitalisation of Rs 7,770.47 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Medplus Health Services Ltd.
- The Medplus Health Services Ltd. 52 Week Low Streak now spans two consecutive sessions, which keeps the focus on persistence rather than a single-day dip.
- The cumulative decline across the streak is 2.86%, giving readers a clearer read on the size of the breakdown.
- The latest 52-week low of Rs 626.45 remains close to the current traded price, keeping the stock near the trough.
- The P/E ratio of 36.06 and P/B ratio of 3.79 remain above the sector median, even after the recent fall.
- The latest Univest data confirms the repeated-low pattern but does not establish a company-specific cause for the move.
About Medplus Health Services Ltd.
Medplus Health Services Ltd. operates in the Retailing sector and the Retailing industry, with a market capitalisation of Rs 7,770.47 crore. For the Medplus Health Services Ltd. 52 Week Low Streak, the business context that matters most is its combination of retail scale, moderate profitability and a valuation that is still above the sector median even after the recent decline.
The company’s ROCE of 22.22% is stronger than the sector median, while ROE of 11.93% is slightly below the benchmark. That mix helps explain why the streak should be interpreted through fundamentals, not just through the daily price print. The Medplus Health Services Ltd. 52 Week Low Streak therefore sits at the intersection of valuation, profitability and a persistent downward price pattern.
Track Medplus Health Services Ltd. Share Price on Univest
Use Medplus Health Services Ltd. (MEDPLUS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Use the Medplus Health Services Ltd. 52 Week Low Streak as a reference point when following future price updates, valuation changes and sector comparison. The key question from here is whether MEDPLUS can move away from repeated yearly lows and stabilise relative to the Retailing benchmark.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
How many sessions has Medplus Health Services Ltd. now set a fresh 52-week low?
Ans. Medplus Health Services Ltd. has set a fresh 52-week low for two consecutive sessions. That makes this a Medplus Health Services Ltd. 52 Week Low Streak rather than a one-day break lower.
What is the cumulative move across the Medplus Health Services Ltd. 52 Week Low Streak?
Ans. The cumulative decline across the Medplus Health Services Ltd. 52 Week Low Streak is 2.86%. This figure comes directly from the latest Univest data and covers the full back-to-back low sequence.
What is the latest 52-week low for MEDPLUS?
Ans. The latest 52-week low is Rs 626.45. The Medplus Health Services Ltd. 52 Week Low Streak shows that the stock has reset its yearly trough on each of the last two sessions.
How does the current valuation compare with the retailing sector?
Ans. MEDPLUS trades at 36.06 times earnings and 3.79 times book, both above the sector medians of 24.03 and 2.38. The Medplus Health Services Ltd. 52 Week Low Streak has not brought the stock below the sector benchmark on valuation.
What do the ROE and ROCE figures suggest?
Ans. ROE is 11.93% and ROCE is 22.22%. In the context of the Medplus Health Services Ltd. 52 Week Low Streak, ROCE compares favourably with the sector median, while ROE is slightly below it.
How does MEDPLUS compare with peers on P/E?
Ans. MEDPLUS’s P/E of 36.06 is above PN Gadgil Jewellers and V2 Retail, close to Electronics Mart India, and below Aditya Vision and Ethos. The Medplus Health Services Ltd. 52 Week Low Streak has not made it the lowest-valued peer on.
Is the stock close to its latest trough?
Ans. Yes. The current traded price of Rs 628.3 is close to the latest 52-week low of Rs 626.45. That keeps the Medplus Health Services Ltd. 52 Week Low Streak in focus for readers watching the next session.
What should investors monitor next?
Ans. Investors can monitor whether MEDPLUS continues to reset the yearly low or begins to trade away from the trough. For the Medplus Health Services Ltd. 52 Week Low Streak, the next key check is whether the stock remains below the.
Recent Articles

Chennai Petroleum Corporation (CHENNPETRO) Share Price Fall Streak: second straight session of decline
9 October 2026

The New India Assurance Company Ltd. (NIACL) Share Price Rise Streak: second straight session with Rs 163.4
9 October 2026

RUNWAL ENTERPRISES (RUNWALENTR) Share Price near all-time low: stock trades at Rs 264.10
9 October 2026

Natco Pharma (NATCOPHARM) Share Price hits fresh 52-week low, now at Rs 792
9 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Chennai Petroleum Corporation (CHENNPETRO) Share Price Fall Streak: second straight session of decline
The New India Assurance Company Ltd. (NIACL) Share Price Rise Streak: second straight session with Rs 163.4
RUNWAL ENTERPRISES (RUNWALENTR) Share Price near all-time low: stock trades at Rs 264.10
Natco Pharma (NATCOPHARM) Share Price hits fresh 52-week low, now at Rs 792
INDEF MANUFACTURING (BAJAJINDEF) Share Price near all-time low as stock trades at Rs 198.85

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





